ghk-cu tolerance downregulation desensitization long-term use effectiveness Peptide: Clinical Evidence & Injectable Protocols The Effect of the Human
Description
For guidance on the broader landscape of peptides used in metabolic and hormonal health, see Peptides for Insulin Resistance: GLP-1, Tesamorelin & Emerging Compounds
Nat Rev Drug Discovery 20:309325 Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y et al (2019) A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
It's advised to use the minimal effective dose and to avoid continuous use 1
Pain on moving the big toe
What this protocol cannot promise No published human trial measures GLOW outcomes
